AMSC Reports Fourth Quarter and Fiscal 2017 Financial Results and Provides Business Outlook
"Fiscal 2017 marked the year we commercialized
Revenues for the fourth quarter of fiscal 2017 were
AMSC’s net loss for the fourth quarter of fiscal 2017 was
Revenues for the full fiscal year 2017 were
Cash, cash equivalents and restricted cash at March 31, 2018 totaled
Business Outlook
For the first quarter ending
Conference Call Reminder
In conjunction with this announcement,
About
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"). Any statements in this release about our expectation that our grid business will grow revenue again in fiscal 2018, our expectation of improved conditions in
UNAUDITED CONSOLIDATED STATEMENTS OF OPERATIONS | |||||||||||||||
(In thousands, except per share data) | |||||||||||||||
Three Months Ended March 31, | Twelve months ended March 31, | ||||||||||||||
2018 | 2017 | 2018 | 2017 | ||||||||||||
Revenues | |||||||||||||||
Wind | $ | 3,828 | $ | 10,447 | $ | 14,294 | $ | 47,269 | |||||||
Grid | 9,670 | 5,748 | 34,109 | 27,926 | |||||||||||
Revenues | 13,498 | 16,195 | 48,403 | 75,195 | |||||||||||
Cost of revenues | 10,504 | 13,360 | 44,608 | 64,352 | |||||||||||
Gross profit | 2,994 | 2,835 | 3,795 | 10,843 | |||||||||||
Operating expenses: | |||||||||||||||
Research and development | 2,904 | 3,736 | 11,594 | 12,540 | |||||||||||
Selling, general and administrative | 5,614 | 6,048 | 22,577 | 25,688 | |||||||||||
Amortization of acquisition related intangibles | 85 | — | 183 | 157 | |||||||||||
Loss on contingent consideration | — | — | 71 | — | |||||||||||
Restructuring and impairment | 199 | 39 | 1,527 | — | |||||||||||
Total operating expenses | 8,802 | 9,823 | 35,952 | 38,385 | |||||||||||
Operating loss | (5,808 | ) | (6,988 | ) | (32,157 | ) | (27,542 | ) | |||||||
Change in fair value of derivatives and warrants | (762 | ) | 636 | 706 | 1,304 | ||||||||||
Gain on sale of minority interests | 216 | — | 1,167 | 325 | |||||||||||
Interest income (expense), net | 53 | (52 | ) | 147 | (383 | ) | |||||||||
Other (expense) income, net | (351 | ) | (415 | ) | (2,800 | ) | 65 | ||||||||
Loss before income tax expense | (6,652 | ) | (6,819 | ) | (32,937 | ) | (26,231 | ) | |||||||
Income tax expense | (657 | ) | 106 | (161 | ) | 1,142 | |||||||||
Net loss | $ | (5,995 | ) | $ | (6,925 | ) | $ | (32,776 | ) | $ | (27,373 | ) | |||
Net loss per common share | |||||||||||||||
Basic | $ | (0.30 | ) | $ | (0.50 | ) | $ | (1.73 | ) | $ | (1.98 | ) | |||
Diluted | $ | (0.30 | ) | $ | (0.50 | ) | $ | (1.73 | ) | $ | (1.98 | ) | |||
Weighted average number of common shares outstanding | |||||||||||||||
Basic | 20,044 | 13,981 | 18,967 | 13,804 | |||||||||||
Diluted | 20,044 | 13,981 | 18,967 | 13,804 | |||||||||||
CONSOLIDATED BALANCE SHEET | |||||||
(In thousands, except per share data) | |||||||
March 31, 2018 |
March 31, 2017 |
||||||
ASSETS | |||||||
Current assets: | |||||||
Cash and cash equivalents | $ | 34,084 | $ | 26,784 | |||
Accounts receivable, net | 7,365 | 7,956 | |||||
Inventory | 19,780 | 17,462 | |||||
Note receivable, current portion | 3,000 | — | |||||
Prepaid expenses and other current assets | 2,947 | 2,703 | |||||
Restricted cash | — | 795 | |||||
Total current assets | 67,176 | 55,700 | |||||
Property, plant and equipment, net | 12,513 | 43,438 | |||||
Intangibles, net | 3,230 | 301 | |||||
Note receivable, long term portion, net of discount of $337K, and net of deferred gain of $105K as of March 31, 2018 | 2,559 | — | |||||
Goodwill | 1,719 | — | |||||
Restricted cash | 165 | 165 | |||||
Deferred tax assets | 542 | 407 | |||||
Other assets | 271 | 233 | |||||
Total assets | $ | 88,175 | $ | 100,244 | |||
LIABILITIES AND STOCKHOLDERS' EQUITY | |||||||
Current liabilities: | |||||||
Accounts payable and accrued expenses | 12,625 | 14,490 | |||||
Note payable, current portion, net of discount of $19 as of March 31, 2017 | — | 1,481 | |||||
Derivative liabilities | 1,217 | 1,923 | |||||
Deferred revenue, current portion | 13,483 | 14,323 | |||||
Total current liabilities | 27,325 | 32,217 | |||||
Deferred revenue, long term portion | 8,454 | 7,631 | |||||
Deferred tax liabilities | 110 | 125 | |||||
Other liabilities | 57 | 45 | |||||
Total liabilities | 35,946 | 40,018 | |||||
Stockholders' equity: | |||||||
Common stock, $0.01 par value, 75,000,000 shares authorized; 21,138,689 and 14,713,839 shares issued at March 31, 2018 and 2017, respectively | 211 | 147 | |||||
Additional paid-in capital | 1,041,113 | 1,017,510 | |||||
Treasury stock, at cost, 165,094 and 97,529 shares at March 31, 2018 and 2017, respectively | (1,645 | ) | (1,371 | ) | |||
Accumulated other comprehensive (loss) income | 883 | (503 | ) | ||||
Accumulated deficit | (988,333 | ) | (955,557 | ) | |||
Total stockholders' equity | 52,229 | 60,226 | |||||
Total liabilities and stockholders' equity | $ | 88,175 | $ | 100,244 | |||
CONSOLIDATED STATEMENTS OF CASH FLOWS | |||||||
(In thousands) | |||||||
Twelve months ended March 31, | |||||||
2018 | 2017 | ||||||
Cash flows from operating activities: | |||||||
Net loss | $ | (32,776 | ) | $ | (27,373 | ) | |
Adjustments to reconcile net loss to net cash used in operations: | |||||||
Depreciation and amortization | 11,459 | 7,519 | |||||
Stock-based compensation expense | 2,692 | 2,892 | |||||
Impairment of minority interest investments | — | — | |||||
Provision for excess and obsolete inventory | 434 | 1,615 | |||||
(Recovery)/Write-off prepaid taxes | (82 | ) | — | ||||
Gain on sale from minority interest investments | (1,167 | ) | (325 | ) | |||
Loss from minority interest investments | — | — | |||||
Change in fair value of warrants and contingent consideration | (635 | ) | (1,304 | ) | |||
Non-cash interest expense | 19 | 156 | |||||
Other non-cash items | 793 | (940 | ) | ||||
Changes in operating asset and liability accounts: | |||||||
Accounts receivable | 1,145 | 11,143 | |||||
Inventory | (2,423 | ) | (815 | ) | |||
Prepaid expenses and other current assets | 558 | 2,729 | |||||
Accounts payable and accrued expenses | (2,956 | ) | (7,938 | ) | |||
Deferred revenue | (1,888 | ) | 1,426 | ||||
Net cash used in operating activities | (24,827 | ) | (11,215 | ) | |||
Cash flows from investing activities: | |||||||
Net cash provided by investing activities | 16,397 | 192 | |||||
Cash flows from financing activities: | |||||||
Net cash provided by (used in) financing activities | 15,278 | (1,130 | ) | ||||
Effect of exchange rate changes on cash and cash equivalents | 452 | (393 | ) | ||||
Net (decrease)/increase in cash and cash equivalents | 7,300 | (12,546 | ) | ||||
Cash and cash equivalents at beginning of year | 26,784 | 39,330 | |||||
Cash and cash equivalents at end of year | $ | 34,084 | $ | 26,784 | |||
RECONCILIATION OF GAAP NET INCOME (LOSS) TO NON-GAAP NET INCOME (LOSS) | |||||||||||||||
(In thousands, except per share data) | |||||||||||||||
Three Months Ended March 31, | Twelve months ended March 31, | ||||||||||||||
2018 | 2017 | 2018 | 2017 | ||||||||||||
Net loss | $ | (5,995 | ) | $ | (6,925 | ) | $ | (32,776 | ) | $ | (27,373 | ) | |||
Gain on sale of interest in minority investments | (216 | ) | — | (1,167 | ) | (325 | ) | ||||||||
Stock-based compensation | 578 | 626 | 2,692 | 2,892 | |||||||||||
Amortization of acquisition-related intangibles | 85 | 39 | 183 | 157 | |||||||||||
Consumption of zero cost-basis inventory | (220 | ) | (254 | ) | (734 | ) | (1,373 | ) | |||||||
Change in fair value of derivatives and warrants | 762 | (636 | ) | (635 | ) | (1,304 | ) | ||||||||
Non-cash interest expense | — | $ | 28 | 19 | 156 | ||||||||||
Tax effect of adjustments | 35 | 41 | 177 | 220 | |||||||||||
Non-GAAP net loss | $ | (4,971 | ) | $ | (7,081 | ) | $ | (32,241 | ) | $ | (26,950 | ) | |||
Non-GAAP net loss per share | $ | (0.25 | ) | $ | (0.51 | ) | $ | (1.70 | ) | $ | (1.95 | ) | |||
Weighted average shares outstanding - basic and diluted | 20,044 | 13,981 | 18,967 | 13,804 | |||||||||||
Reconciliation of Forecast GAAP Net Loss to Non-GAAP Net Loss | ||||
(In thousands, except per share data) | ||||
Three months ending | ||||
June 30, 2018 | ||||
Net loss | $ | (7,000 | ) | |
Stock-based compensation | 900 | |||
Amortization of acquisition-related intangibles | 100 | |||
Consumption of zero-cost inventory | (100 | ) | ||
Tax effect of adjustments | — | |||
Non-GAAP net loss | $ | (6,100 | ) | |
Non-GAAP net loss per share | $ | (0.30 | ) | |
Shares outstanding | 20,100 | |||
Note: Non-GAAP net loss is defined by the Company as net loss before gain on sale of interest in minority investments; stock-based compensation; amortization of acquisition-related intangibles; consumption of zero cost-basis inventory; non-cash interest expense; change in fair value of derivatives and warrants; and other unusual charges, net of any tax effects related to these items. The Company believes non-GAAP net loss assists management and investors in comparing the Company’s performance across reporting periods on a consistent basis by excluding these non-cash, non-recurring or other charges that it does not believe are indicative of its core operating performance. The Company is not able to provide the change in fair value of warrants and contingent consideration on a forward-looking basis without unreasonable efforts because the calculation for that change is primarily driven by the closing price and volatility of the Company's stock at the end of each fiscal quarter, which cannot be reasonably estimated at this time. The Company also regards non-GAAP net loss as a useful measure of operating performance to complement operating loss, net loss and other GAAP financial performance measures. In addition, the Company uses non-GAAP net loss as a factor to evaluate the effectiveness of its business strategies.
Generally, a non-GAAP financial measure is a numerical measure of a company's performance, financial position or cash flow that either excludes or includes amounts that are not normally excluded or included in the most directly comparable measure calculated and presented in accordance with GAAP. The non-GAAP measures included in this release, however, should be considered in addition to, and not as a substitute for or superior to, operating income, cash flows, or other measures of financial performance prepared in accordance with GAAP. A reconciliation of non-GAAP to GAAP net loss is set forth in the table above.
AMSC Contact:
AMSC Investor Relations
Phone: 424-634-8592
Email: Brion.Tanous@amsc.com
Source: AMSC